###### Strengths and limitations of this study

-   This is the first study in Australia to target specifically Indigenous smoking during pregnancy that covers three different states and different settings.

-   This study is designed to overcome specific implementation issues identified in previous research, including ensuring community representation in governance of the research; participant recruitment by known health staff from the service; and adequate reimbursement for time and effort of services and women.

-   The intervention tested in this study was informed by theory and based on extensive formative research beforehand.

-   This study is a pilot study aimed to assess feasibility and acceptability, and is not powered to assess the effectiveness of the intervention.

-   This study covers health professionals treating Indigenous pregnant women who work at Aboriginal Medical Services only, and does not cover other general antenatal care settings that Indigenous women may attend.

Introduction {#s1}
============

Tobacco smoking in pregnancy is the most important preventable risk factor for poor maternal and infant health outcomes.

In 2013, 12% of women who gave birth in Australia smoked during pregnancy.[@R1] Indigenous Australian women have the highest smoking prevalence during pregnancy (47%).[@R1] Indigenous women also quit smoking during pregnancy at a lower rate compared with the general population (11% compared with 25%).[@R1] Smoking has been identified as an important contributor to the health and life expectancy gaps between the Indigenous and non-Indigenous people in Australia.[@R2]

Barriers to quitting {#s1a}
--------------------

Australian Indigenous pregnant women face multiple barriers to quitting smoking.[@R3] These include social norms of smoking in some Indigenous communities, multiple life stressors, lack of prioritisation of smoking cessation, lack of support for cessation, lack of salience of antitobacco messages and inadequate access to targeted programmes.[@R4] Health professionals report they are ill-equipped to tackle the complexities of smoking cessation care for pregnant women, and lack resources and optimism.[@R8] First-line medications (oral nicotine replacement therapy (NRT)) are currently not subsidised in Australia,[@R3] disproportionally impacting lower socioeconomic populations and Indigenous women.[@R10]

Evidence for smoking cessation care in pregnancy {#s1b}
------------------------------------------------

The combination of behavioural counselling and pharmacotherapy has been shown to be the most effective treatment for smokers generally.[@R11] Studies specific to pregnant women have also shown that psychosocial interventions such as counselling are effective.[@R12] Recently a taxonomy was developed and validated to detail the specific 'active ingredients' of behavioural counselling termed behaviour change techniques.[@R13] These include, for example, goal setting and identifying smoking triggers.[@R16]

Pharmacotherapy {#s1c}
---------------

In a Cochrane review on pharmacotherapy for smoking cessation in pregnancy, the use of NRT increased cessation rates by 40% (RR 1.41, 95% CI 1.03 to 1.93); the exclusion of non-placebo controlled trials resulted in a lower, non-significant increase in the cessation rate (RR 1.28, 95% CI 0.99 to 1.66).[@R17] The discrepancy between these findings, and the apparent effectiveness of NRT for the general population,[@R18] may be explained by the faster nicotine metabolism in pregnancy, requiring higher doses than those used in the included studies.[@R17] Importantly, the use of NRT was not associated with any significant differences in pregnancy or birth outcomes.[@R17] Experts agree that NRT is always safer than smoking in pregnancy, and guidelines from several countries, including Australia, recommend the use of NRT, if a woman has been unsuccessful in quitting.[@R21] These guidelines recommend first using oral forms of NRT, and if the woman is still unsuccessful quitting smoking, adding an NRT patch. This is done to ensure that the lowest effective dose is used.[@R22]

Need for health professionals' training {#s1d}
---------------------------------------

Health professionals report that they lack the knowledge, skills and confidence to assist pregnant women to quit smoking. A recent national Australian cross-sectional survey[@R9] found that few general practitioners (GPs) and obstetricians routinely perform all of the required components of the clinical guidelines.[@R11] Furthermore, only 11% reported always prescribing NRT, 7% arranging follow-up, 22% discussing the psychosocial context of smoking and 26% referring to a specialised cessation programme (such as the national Quitline). Surveys with other antenatal health professionals in Australia (Aboriginal health workers, midwives, nurses) report similar findings.[@R8]

These findings mirror surveys internationally,[@R25] portraying an evidence-practice gap in the way health professionals currently manage smoking in pregnant women.

Addressing this gap is crucial, as it has been shown that advice from health professionals increases the chances of a quit attempt in the general population (RR 1.66, 95% CI 1.42 to 1.92),[@R40] and is positively associated with intention to quit in Australian Indigenous smokers of reproductive age (OR 3.82, 95% CI 1.43 to 10.2).[@R41] Training health professionals has been proven to increase rates of smoking cessation (OR=1.60, 95% CI 1.26 to 2.03),[@R42] although this has not been studied specifically for Indigenous pregnant women.

Interventions for pregnant Indigenous smokers {#s1e}
---------------------------------------------

Interventions developed to address smoking in Indigenous people have often lacked either rigorous evaluation or deep cultural understanding.[@R43] Two randomised controlled trials (RCTs) among Indigenous pregnant smokers have been conducted: one in Indigenous Australians, and the other in Alaska native women.[@R45] Neither demonstrated any statistically significant differences between intervention and control groups, although the underpowered Eades' study found an assisted quit rate of 11% compared with a control rate of 5%.[@R45] Several implementation factors marred the outcomes of these studies, including low enrolment, high attrition and possible contamination between study arms.[@R45] Patten\'s study included NRT only through referral to a separate programme;[@R46] Eades' study included an option for NRT at the third visit, after 7--10 days of unsuccessful quit attempts.[@R45]

The Indigenous Counselling and Nicotine (ICAN) QUIT in Pregnancy intervention {#s1f}
-----------------------------------------------------------------------------

In 2015, a pragmatic guide to the management of smoking cessation in Indigenous pregnant women was published.[@R47] These guidelines are structured on the ABC pathway (Ask about tobacco use; Brief advice to quit; Cessation support),[@R23] with the addition of a D component (Discuss the psychosocial context of smoking)[@R47] the ABCD approach. A proactive approach is recommended---offering assistance to all pregnant smokers (regardless of readiness to quit and smoking level) and an expedited offer of NRT after 1--2 days of an unsuccessful quit attempt.[@R47] These guidelines follow other Australian clinical guidelines, recommending the use of oral NRT as first line, higher doses of NRT due to the higher metabolism in pregnancy and combination NRT if needed.[@R21]

On the basis of these ABCD guidelines,[@R47] we used the Theoretical Domains Framework,[@R49] the Behaviour Change Wheel[@R50] and Behaviour Change Techniques recommended in pregnancy,[@R16] to develop a theory-based behaviour change intervention aimed to improve health professionals management of smoking in Indigenous pregnant women---ICAN QUIT in Pregnancy. The Theoretical Domains Framework and Behaviour Change Wheel are used to identify barriers and facilitators to achieving evidence-based care to inform intervention design.[@R50]

The intervention was developed in collaboration and negotiation with two Aboriginal Medical Services (AMSs) in New South Wales (NSW). The chief executive officers of those AMSs are associate investigators on the study and partnered with the research team to establish a Stakeholder and Consumer Aboriginal Advisory Panel (SCAAP), to advise on the design of the study. They also contributed to a working party including AMSs staff and community members that developed educational resources for the intervention. This collaborative process of intervention development has been described elsewhere.[@R51]

The aim of this study is to test the feasibility and acceptability of the ICAN QUIT in Pregnancy intervention to increase health professionals\' provision of evidence-based, culturally responsive smoking cessation care to Australian Indigenous pregnant smokers, positioning Aboriginal women and communities at the centre of the research with engagement and ownership upheld through the study.[@R51] This study will inform the final design and implementation of a clustered RCT (cRCT) aimed to study the effectiveness of health professionals\' training on smoking cessation rates in pregnant Australian Indigenous smokers.

Methods and analysis {#s2}
====================

Study overview {#s2a}
--------------

The overall objective is to reduce smoking in Aboriginal and/or Torres Strait Islander pregnant women.

Specific aims of this pilot are:

Primary aims {#s2b}
------------

Assess feasibility and acceptability of a multicomponent targeted intervention to train health professionals at AMSs in the culturally responsive management of smoking in Australian Indigenous pregnant women.

Secondary aims {#s2c}
--------------

1.  Assess the effectiveness on NRT prescribing practices.

2.  Evaluate the effectiveness on health professionals\' knowledge, attitudes and practices in managing smoking in pregnant Indigenous women.

3.  Estimate the trends for quit attempts and biochemically verified smoking cessation rates in pregnant patients managed by trained health professionals.

4.  Assess patients\' perceived receipt and quality of smoking cessation care by the trained health professionals.

5.  Evaluate changes in the perceived well-being of pregnant patients.

6.  Evaluate behaviour change techniques use by the trained health professionals.

Study design {#s2d}
------------

This is a step-wedge cluster randomised pilot study with six participating sites randomised to three clusters (each of two AMSs). Allocation of the sites to the clusters is based on geographical convenience. For each cluster, the period of treatment crossover was randomised using simple randomisation. Allocation concealment was not possible. All of the sites will receive the same intervention which will be sequentially delivered 2 months following commencement of the study, staggered by 1 month between clusters (the intervention is described below). Two cohorts, one of health professionals and one of pregnant women, will provide data with repeated measures: from 2 months prior to receiving the intervention until 6 months following the intervention. See [figure 1](#F1){ref-type="fig"} for a schematic illustration.

![Schematic illustration of the step-wedge cluster study for the Indigenous Counselling And Nicotine (ICAN) QUIT in Pregnancy Pilot Study.](bmjopen-2017-016095f01){#F1}

A step-wedge design was chosen since it allows the intervention to be delivered sequentially and therefore reduces the cost and burden of simultaneous implementation, while also providing some control of confounding factors through randomisation.[@R52] Furthermore, this design will ensure all sites receive the intervention which is important from an ethical viewpoint. The cluster design was chosen to prevent contamination, a problem identified in the Eades' study.[@R45]

Timeline of the study {#s2e}
---------------------

November 2016 to September 2017.

Setting {#s2f}
-------

Urban and regional AMSs in NSW, Queensland and South Australia. The AMSs include Aboriginal Community Controlled Health Services which are non-government organisations operated by local Aboriginal and Torres Strait Islander communities, to deliver holistic, comprehensive and culturally appropriate healthcare to the communities that control them through an elected board of management.[@R53]

Inclusion criteria {#s2g}
------------------

For participating services AMSs are included if they fulfil all of the following criteria:Diagnose pregnancy or provide antenatal or routine care for pregnant Aboriginal or Torres Strait Islander women.Employ at least one General Practitioner (GP).Have contact with at least 20 pregnant women who smoke per year.Are able to recruit and follow patients as required.

Participating health professionals are those who: consult with pregnant women either for confirmation of pregnancy, antenatal care and/or routine care.

Participating women will include those who fulfil all of the following criteria:Pregnant, ≤28 weeks gestation.Aboriginal and/or Torres Strait Islander or expectant mothers of Aboriginal and/or Torres Strait Islander babies.Aged ≥16 years old.Smoke tobacco at any level of consumption, including those that only smoke occasionally.

Intervention components {#s2h}
-----------------------

The ICAN QUIT in Pregnancy intervention includes:**Training** of health professionals in participating sites through webinar in three 60-min weekly sessions. The training will be delivered by two experienced tobacco treatment specialists. Content will include background on smoking in pregnancy including the Indigenous context; the ABCD approach, and the use of NRT in pregnancy (see  online [supplementary file](#SP1){ref-type="supplementary-material"} for full description of webinar content). As an incentive to complete the training, all health professionals will be offered continuing professional development points (required as part of registration with the Australian Health Practitioner Regulation Agency).**An educational resources package**, to be used by both health professionals and pregnant women, has been developed collaboratively and includes a training manual for health professionals, and flip chart, patient booklet and educational posters for engaging with the pregnant women. Resources were developed by a medical doctor and tobacco treatment specialist (YBZ) and Aboriginal researcher (MB) in consultation with AMSs. These have been rigorously pretested using a four-step process, including review by an expert panel, assessment using a suitability of material score by two Aboriginal health workers, readability scores, and focus groups reviews with both health professionals, and female Aboriginal community members, in three states.[@R54]**Oral forms of NRT** for the pregnant women will be supplied to the sites free of charge, as these are not currently subsidised in Australia. All available forms in Australia will be included (gum, lozenge, mini lozenge, inhalator and spray). NRT will be dispensed through a voucher system. Sample packs will be provided directly to the sites to introduce patients to the selection available. If NRT patches are required, the GP at the service will write a government-subsidised prescription. NRT will be used according to product and Therapeutic Goods Administration instructions, as well as health professionals\' judgement on a patient-by-patient basis. No study-specific protocol to NRT dispensing will be followed. As nicotine has potential effects on the fetus,[@R55] a risk-benefit analysis will be undertaken with each woman when NRT is offered, as recommended in clinical guidelines.[@R21] A participant not using NRT can remain in the study with behavioural support only.**Audit and feedback** regarding health professionals\' performance will be via aggregated, deidentified, service-specific, monthly data collection, commencing in the pretraining phase and continuing through to study completion. Each service will receive feedback regarding their rate of NRT prescription to pregnant women who smoke compared with other study services. 10.1136/bmjopen-2017-016095.supp1Supplementary data

Study implementation {#s2i}
--------------------

A staff member will be nominated as a research facilitator by each service. The role of the research facilitator is to recruit patients, conduct surveys and evaluations, and collect feasibility data ([table 1](#T1){ref-type="table"}). The research facilitator will be trained by the research team in a face-to-face meeting and provided with supporting resources (detailed instructions and checklist) to assist them in their role. The research team will provide three site visits (before commencement, 1 month after commencement and end of study) and weekly telephone calls as implementation support. Additional support will be provided as needed by the research facilitator.

###### 

Feasibility and acceptability outcomes

  Hierarchy of measurement (service, Health Professionals or pregnant women)   Outcome                                            Data collection method               Analysis                                                                                                                                                        Time-points
  ---------------------------------------------------------------------------- -------------------------------------------------- ------------------------------------ --------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------
  Service                                                                      Recruitment rate (primary outcome)                 Research facilitator log             Number of women recruited divided by number of women approached for each site, overall sites and stratified by site                                             End of study
  Service                                                                      Follow-up rate                                     Participant survey                   Percentage of women recruited who complete all follow-up surveys                                                                                                4 weeks and 12 weeks
  Service                                                                      Proportion of women\'s checklists completed        Women\'s checklist                   Number of consultations with a completed checklist divided by the total number of consultations for each patient (designated and non-designated study visits)   End of study
  Service                                                                      Provider training rate                             Research facilitator log             Number of providers undergoing webinar training divided by the total number of providers, overall sites and stratified by site                                  End of training
  Service                                                                      Webinar completion rate                            Research facilitator log             Number of webinar sessions each provider attended                                                                                                               End of training
  Health professionals and pregnant women                                      Acceptability of intervention and implementation   Interviews with staff and patients   Thematic analysis                                                                                                                                               End of study

Recruitment and reimbursement {#s2j}
-----------------------------

Services will be recruited through: (1) written invitation to all AMSs in NSW asking for expressions of interest, and (2) targeted invitations to services that worked previously with the researchers. The service will be reimbursed \$6000 in instalments, for the involvement of their nominated research facilitator.

Service staff will aim to recruit all pregnant smokers under their care when they attend for any type of service including confirmation of pregnancy, antenatal care or routine care. The study will be advertised through posters at the service.

The research facilitator will complete a one-page eligibility checklist with women interested in the study, and if they are eligible, will gain informed consent. Consenting women will be assigned a unique code to link the data collected to the same participant. Pregnant women recruited to the study will be asked to attend three designated study visits (baseline at recruitment, 4 weeks and 12 weeks postrecruitment). At each study visit, the participating women will be asked to fill out two to three online surveys and perform a breath carbon monoxide test. We estimate that each study visit will take between 30 min and 50 min.

Women will receive reimbursement for their time in the form of a \$A20 shopping voucher for each visit (total \$A60). Women attending all three study visits will enter into a draw for one baby pack (value \$A50) per site.

Outcomes {#s2k}
--------

Outcomes include feasibility and acceptability measures, and measures of effectiveness outcomes (detailed description of all the outcomes are presented in [tables 1 and 2](#T1 T2){ref-type="table"}). The primary outcome will be the recruitment rate of participating pregnant women defined as the number of eligible women who consented to participate in the study.

###### 

Measures of effectiveness outcomes

  Hierarchy of measurement (service, Health Professionals or pregnant women)   Outcome                                                                                Data collection method               Analysis                                                                                            Time points
  ---------------------------------------------------------------------------- -------------------------------------------------------------------------------------- ------------------------------------ --------------------------------------------------------------------------------------------------- ----------------------------------------------------
  Service                                                                      Proportion of pregnant smokers that were given nicotine replacement therapy (NRT)      Audit of deidentified grouped data   Pharmaceutical Benefit Scheme (PBS)\* prescriptions or vouchers for NRT                             Monthly
  Health professionals                                                         Self-reported knowledge, attitudes and practices about managing smoking in pregnancy   Health Professionals surveys         Changes in knowledge, attitudes and practices comparing all time points                             Pretraining, post-training and end of study
  Health professionals                                                         Behaviour change techniques (BCT)                                                      Audio recording of consultations     Analysis of transcripts by trained BCT coders                                                       Pretraining and post-training
  Pregnant women                                                               Self-reported smoking characteristics                                                  Smoking characteristics survey       Changes in smoking characteristics                                                                  Baseline, 4 weeks and 12 weeks
  Pregnant women                                                               Women\'s perception of receiving smoking cessation care                                Women\'s checklist                   Composite scores on checklists                                                                      Exit from consultations with a Health Professional
  Pregnant women                                                               Self-reported quit rates                                                               Smoking Characteristics Survey       7-day point prevalence and continuous abstinence[@R74]                                              Baseline, 4 weeks and 12 weeks
  Pregnant women                                                               Biochemically validated quit rates                                                     Handheld CO metre                    7-day point prevalence and continuous abstinence[@R74] using expired CO\<6 ppm as reference point   Baseline, 4 weeks and 12 weeks
  Pregnant women                                                               Self-report of adherence to NRT                                                        Smoking characteristics survey       Changes in adherence to NRT                                                                         4 weeks and 12 weeks
  Pregnant women                                                               Self-reported knowledge, attitudes and smoking behaviours                              Smoking Characteristics Survey       Changes in knowledge, attitudes and smoking behaviours                                              Baseline, 4 weeks and 12 weeks
  Pregnant women                                                               Growth and empowerment                                                                 Growth and Empowerment Survey        Changes in growth and empowerment domains                                                           Baseline, 4 weeks and 12 weeks
  Pregnant women                                                               Critical success measures                                                              Critical Success Survey              Descriptive analysis of the nine critical success factors                                           End of study

\*Pharmaceutical Benefit Scheme (PBS) is the Australian government scheme for prescription subsidy

Data collection and instruments {#s2l}
-------------------------------

Data will be collected at three levels---(1) service (2) health professionals and (3) pregnant women ([tables 1 and 2](#T1 T2){ref-type="table"}). Participant timelines are presented in [table 3](#T3){ref-type="table"} (health professionals) and [table 4](#T4){ref-type="table"} (pregnant women).

###### 

Schedule of assessments for health professionals receiving training for Indigenous Counselling And Nicotine (ICAN) QUIT in Pregnancy Pilot Study

  Assessment                                            Performed by               Pretraining   Post-training   End of study
  ----------------------------------------------------- -------------------------- ------------- --------------- --------------
  Informed consent                                      Research facilitator       **X**                         
  Pretraining survey                                    Self-administered online   **X**                         
  Audio recording of smoking consultations (optional)   Health professional        **X**         **X**           
  Post-training survey                                  Self-administered online                 **X**           **X**
  Interview                                             Research team                                            **X**

###### 

Schedule of assessments for pregnant women participating in Indigenous Counselling And Nicotine (ICAN) QUIT in Pregnancy Pilot Study

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Assessment                                           Performed by                                      Day 0   Any additional follow-up\*   **4** weeks\      **12** weeks\     End of study
                                                                                                                                              **(+/−3 days)**   **(+/−7 days)**   
  ---------------------------------------------------- ------------------------------------------------- ------- ---------------------------- ----------------- ----------------- --------------
  Review eligibility for study                         Health professional and/or research facilitator   **X**                                                                    

  Informed consent                                     Research facilitator                              **X**                                                                    

  Smoking characteristics survey                       Research facilitator                              **X**                                **X**             **X**             

  Growth and Empowerment survey                        Research facilitator                              **X**                                **X**             **X**             

  Critical Success Measures survey                     Research facilitator                                                                                     **X**             

  Breath carbon monoxide test                          Research facilitator                              **X**                                **X**             **X**             

  Patient checklist                                    Research facilitator                              **X**   **X**                        **X**             **X**             

  Audio recording of smoking consultation (optional)   Health professional                               **X**   **X**                        **X**                               

  Interview                                            Research team                                                                                                              **X**
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

\*Any additional follow-up (not part of designated study visits) including all of her visits to the service for usual care.

### Service level {#s2l1}

#### Research facilitator log {#s2l1a}

Feasibility data will be collected by the research facilitator using a designated log, including recruitment rate, follow-up rate, proportion of participant surveys completed and health professionals\' training rate. Reasons for non-participation or withdrawal will not be collected routinely as part of the research facilitator designated log, but will be discussed with the research facilitator on an ongoing basis in the weekly implementation phone calls and at the end of the study interview.

#### Aggregated computerised data {#s2l1b}

Deidentified aggregated monthly computerised data will be collected from study commencement ([figure 1](#F1){ref-type="fig"}), including: number of pregnant women attending the service; number of those that smoke; number referred to the Quitline and number of NRT prescriptions (including oral NRT vouchers).

### Health professionals level {#s2l2}

#### Health professionals\' survey {#s2l2a}

A 102-item, 15 min, self-administered online survey will include questions about health professionals\' demographic characteristics; self-reported knowledge, attitudes and provision of smoking cessation care; prescription of NRT; self-assessment of the barriers and enablers to providing smoking cessation care; and perceived usefulness of educational resources. This survey is based on a previous survey from a national study of 378 GPs and obstetricians.[@R9] The survey will be sent pretraining and post-training, and at the end of the study ([table 3](#T3){ref-type="table"}).

Health professionals\' demographic characteristics include: gender, age, years working as a health professional (less than 10 years; 10--19 years; 20 or more years), specialty (GP; midwife; nurse; Aboriginal health worker; other), smoking status (daily; occasionally, ex-smoker, never smoked) and average number of pregnant women who smoke seen per month (\<5, 5--10,\>10).

Self-reported provision of smoking cessation care: will be measured using 5-point Likert Scales (never (0%); occasional (1%--25%); sometimes (26%--50%); often (51%--75%); always (76%--100%)) on the various components of smoking cessation care ('How often do you provide the following types of cessation care with pregnant women?' ask; record smoking status; brief advice; assess nicotine dependence; measure carbon monoxide; cessation support; discuss psychosocial context; follow-up; referral to Quitline; referral to other specialist cessation support; involve family members).

Prescription of NRT and attitudes towards prescribing NRT during pregnancy: NRT prescription will be measured with the 5-point Likert Scale as for the other smoking cessation care components. Self-reported perceptions on NRT in pregnancy will include rating the safety for the fetus, effectiveness in aiding pregnant smokers to quit and perceived adherence.

Barriers and enablers to smoking cessation care: (5-point Likert Scales---strongly disagree, to strongly agree). This will be measured using 22 statements covering 13 domains from the Theoretical Domains Framework,[@R50] including: knowledge, reinforcement, role/identity, beliefs about capabilities, optimism, beliefs about consequences, social influence/subjective norm, goals/priority, memory/attention, environmental context and resources, emotions/stress, intentions, behavioural regulation. Most domains include one question regarding smoking cessation care during pregnancy in general, and one question specifically regarding the prescription or recommendation of NRT.

The 'Knowledge' domain will also be measured with one question about guidelines (\'Have you read any of the following smoking cessation guidelines?\' With a list of 3 different national guidelines, yes/no); and 24 true/false statements that will be computed to form a composite score. The 'Skills' domain will be measured with one question (\'Have you received any training in tobacco management related to pregnancy? with a list of 4 training types\' yes/no).

Usefulness of educational resources will be measured using 5-point Likert Scales (not useful at all to very useful) for each webinar session and each educational resource.

#### Interviews {#s2l2b}

At the conclusion of the study, one of each type of health professionals from each service (ie, a midwife, a GP and an Aboriginal health worker), including also the manager and research facilitator, will be interviewed. Recruitment will continue until saturation of themes. Estimated sample n=40. The objective of the interviews is to assess the feasibility of the intervention and the study, and gain valuable insights before commencing the cRCT. The semistructured interview guide will include questions based on the Theoretical Domains Framework and Behaviour Change Wheel,[@R49] and include topics such as the challenges to implementing the study, and what could have been done to improve the study.

### Pregnant women level {#s2l3}

#### Smoking characteristics survey {#s2l3a}

This 56-item, 15 min, survey will incorporate questions from a previously tested survey in Aboriginal pregnant smokers.[@R57] Demographic and smoking characteristics will include: age, Aboriginal and Torres Strait Islander status, partner status, parity, number of children, any child living at home, smoking status, measures of nicotine dependence (Fagerstrom Test of Nicotine Dependence,[@R58] Heaviness of Smoking Index,[@R59] strength and frequency of urges to smoke[@R60]), home smoking rules, intentions to quit smoking, number of previous quit attempts ≥24 hours, use of other smoking cessation resources (such as the Quitline), symptoms of nausea in pregnancy (morning sickness is a predictor of spontaneous quitting[@R62]), the Risk Behaviour Diagnosis Scale (previously validated in Aboriginal smokers, adapted here for pregnant smokers[@R63]), and attitudes to smoking and quitting. Adherence to NRT will be measured using a 5-item multichoice question (did not take it all; used occasionally 1--2 times a week; used 3--4 times but not all doses; occasionally missed a dose; used most doses, every day).

At the 4-week and 12-week follow-ups, the survey includes additional questions to determine 7-day point prevalence smoking abstinence and continuous abstinence rates.[@R64]

#### Growth and empowerment measure (GEM) {#s2l3b}

This survey has been previously validated with 184 Indigenous Australians, but has not been used specifically with Indigenous pregnant women[@R65] and includes two components:14-item Emotional Empowerment Scale which comprises two domains: inner peace and self-capacity.12 Scenarios with two domains: healing and enabling growth and connection and purpose.

These are accompanied by the 6-item Kessler Psychological Distress Scale supplemented by two questions assessing frequency of happy and angry feelings. Estimated completion time is 15 min.

#### Critical success measure {#s2l3c}

This measure was developed through analysis of six Indigenous youth social and emotional well-being programmes[@R66] and was previously used in the evaluation of an urban art-based community health programme with young Aboriginal and Torres Strait Islander parents.[@R67] This survey will be completed only once at the 12-week visit. This survey will measure nine factors relevant to an empowerment-based programme, including adopting full commitment to working from strengths; being patient to develop the relationship bond first; modelling reliability and being consistent; facilitating connection to culture; adopting a non-judgemental approach; setting rules and boundaries; modelling openness, honesty, hope and trust; maximising opportunity for choice making, self-motivation, feeling safe to try new things; celebrating small achievements and positive changes. For each factor, we will use 5-point Likert Scales to measure women\'s perception of the importance of the factor (from not at all to absolutely essential) and how well the intervention achieves this (from poorly to extremely well). Estimated completion time is 15 min.

#### Breath carbon monoxide {#s2l3d}

At the three study visits, a breath carbon monoxide test will be performed to validate smoking status, and estimate fetal carboxyhaemoglobin. Carbon monoxide level ≥5 ppm=96% sensitivity and 99.6% specificity for agreement of carbon monoxide readings and self-report of smoking in Aboriginal communities.[@R68]

#### Women\'s checklist {#s2l3e}

At the end of any visit to the service, from recruitment to the end of follow-up, including the designated study visits at 4 weeks and 12 weeks, the patient will be asked to complete a 1 min online checklist on a computer tablet. The survey will commence with a question regarding which health professional she saw on that occasion (GP/midwife/nurse/Aboriginal health worker/other). Eleven dichotomous questions (yes/no) will be used to form a composite score representing quality of smoking cessation care. For example: *Did any of the health professionals you saw today give you the following care: Asked you about smoking? Gave you advice to quit...? Assisted you with making a quit plan? Explained how smoking affects...? Offered you NRT...? Measured your breath...? /Discussed with you...? Gave you support...? Made arrangements for follow-up appointments or referral? Gave you resources...?* Two Likert Scales will be used to rate (1) her perceived involvement in making a decision about quitting (no involvement to very much involved) and (2) her overall satisfaction with the help she received (not satisfied at all to very satisfied).

#### Recording of consultations for behaviour change techniques analysis {#s2l3f}

A digital audio recording of provider-patient sessions relating to smoking cessation will be undertaken, including a mix of initial and follow-up consultations (ie, prequit attempt, and during or postquit attempt up to the 4-week follow-up point). A total estimate of 54 consultations will be recorded (nine consultations per service---three pregnant smokers from each service, for each woman, three consultations as outlined above).

#### Interviews {#s2l3g}

At the conclusion of the study, approximately three to four women from each service, will be interviewed to assess the feasibility of the intervention and related research in order to gain insights before the cRCT. Key topics to be discussed include their perceptions of the usefulness, acceptability and potential effectiveness of the support they received as part of the study, and what could have been done to improve this. Recruitment will continue until saturation of themes.

Sample size calculation {#s2m}
-----------------------

Health professionals\' sample: expected sample size will be six services, training 5--10 per service, with total sample size of n=30--60 recruited health professionals. Expected completion of training is 80%.

Pregnant women\'s sample: expected recruitment is 10 eligible consenting women per service n=60 (range 50--80). Assuming a true recruitment rate of 50%, a sample of 200 eligible women will allow estimates of the true recruitment rate within a 7% margin of error.

Data analysis plan {#s2n}
------------------

Recruitment rates (and other feasibility outcomes specified in [table 1](#T1){ref-type="table"}) will be estimated as proportions (or percentages) with 95% CIs, SEs will be adjusted for the clustered design using the clustered jackknife.[@R69] All primary analysis will be according to the intention-to-treat principle, such that each site (and participants within) will be analysed according to the time at which the site crossed over to the intervention period.

### Analysis of effectiveness outcome measures {#s2n1}

1.  Changes in the proportion of eligible women that were prescribed NRT from pretraining to post-training will be assessed using a logistic mixed effects regression model. The model will include a categorical effect of time, an indicator of period (pretraining vs postintervention) and a random intercept for each site.

2.  Changes in provider knowledge/attitudes relating to smoking cessation in pregnant mothers measured by self-administered survey: pretraining to post-training and end of study will be investigated using generalised linear mixed effects models, with random effects for the site and the health professionals, and fixed effects for time. If the fraction of missing data is less than 5% the primary method will be based of those with completed surveys from both time points. Otherwise we will use multiple imputation under the missing at random assumption, with a sensitivity analysis using pattern mixture models to explore the potential that data is missing not at random.

3.  Trends in smoking characteristics and growth and empowerment, and factors associated with smoking characteristics and growth and empowerment, will be assessed using generalised linear mixed models.

4.  Two certified behaviour change techniques coders will independently code the transcribed audio recordings. Discrepancies will be resolved through discussion with a third coder. Coding will be based on the taxonomy of 44 smoking cessation behaviour change techniques.[@R15] Additionally, the two coders will independently code the training resources. Inter-rater agreement levels will be calculated. We will assess changes between behaviour change techniques present pretraining and post-training; and the fidelity between the behaviour change techniques present in the training resources and those present in the post-training recordings.

5.  Interviews at the end of the study will be audio recorded, transcribed and analysed (using NVivo software) with a framework analysis[@R70] based on the Theoretical Domains Framework and Behaviour Change Wheel.[@R49] Two researchers will independently open code and index a 20% proportion of the transcripts line by line, using a predetermined coding matrix. After coming to consensus, one researcher will then complete the coding and indexing. If appropriate, inductive themes will be included after discussion between the two researchers.

Ethics and dissemination {#s2o}
------------------------

We will follow Australian National Health and Medical Research Council ethical guidelines for research, including Aboriginal and Torres Strait Islander research, consistent with the Declaration of Helsinki.[@R71]

The Stakeholder and Consumer Aboriginal Advisory Panel (SCAAP) invites at least one member from each of the pilot study AMSs and will convene bimonthly. The role of the SCAAP will be to provide cultural consultation, advice and direction to ensure that the implementation of the ICAN QUIT in Pregnancy project pilot is acceptable and respectful to the Aboriginal communities involved. The SCAAP is instrumental in ensuring research practice, data collection and dissemination of findings is appropriate to each community. Members of SCAAP will be included in the writing and publication of research results.

Furthermore, an Aboriginal cultural liaison position is maintained throughout the study to ensure appropriate level of cultural safety, Aboriginal community ownership and engagement is upheld. The research team includes three Aboriginal chief investigators and four Aboriginal associate investigators who are involved in various aspects of the project, including the design, implementation, data analysis and interpretation.

Pregnant smokers who are mature minors (aged over 16 years but under 18 years) will be included if judged by the research facilitator able to give informed consent. Consent to the audio recording is an additional option for both health professionals and participating pregnant women, which they can agree to or decline.

All of the data collected, at all levels, are deidentified. Pregnant women participating in the study are given a unique code by the research facilitator. Any data collected are only identified with this code. Health professionals\' surveys are linked using the date of birth and the last three digits of their surname.

All serious adverse events, and study related adverse events considered severe in nature that do not otherwise fulfil the definition of a serious adverse event, will be reported immediately by sites during follow-up. For the purposes of this study those events that will be considered severe study related adverse events include, but are not limited to, severe allergic reaction to NRT and clinical depression. A data monitoring committee will not be convened for this study and was not deemed necessary by the human research ethics committee, as NRT will be used according to current clinical guidelines.

Study outcomes will be discussed with participating services. Sites will receive a lay summary of the study outcomes, to be distributed to their community and participants of the study as they see fit. A policy brief will be distributed to Aboriginal and Government peak bodies.

Significance of the study {#s2p}
-------------------------

The ICAN QUIT in Pregnancy intervention trial was designed to overcome implementation problems identified in previous research.[@R45] This includes ensuring community representation in governance of the research; participant recruitment by known health staff from the service; adequate reimbursement for time and effort of the services and women participants. This pilot phase will enable us to test the feasibility and acceptability of the intervention, and make further adjustments as necessary, prior to the expense of a large cRCT. The ICAN QUIT in Pregnancy pilot trial will provide valuable information to advance the much needed reduction in smoking rates among pregnant Indigenous women.
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